Pfizer Inc

NYSE: PFE
$27.76
-$0.33 (-1.2%)
Closing Price on November 4, 2024

PFE Stock Chart and Intraday Price

PFE Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 235 E 42ND ST, NEW YORK, NY, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 150,147.88M USD
Shares Outstanding 5,646,780,000
Pfizer Inc. is a global leader in biopharmaceuticals, offering a wide range of medicines and vaccines. The company focuses on various therapeutic areas including cardiovascular, infectious diseases, women’s health, chronic immune and inflammatory diseases, and more. Pfizer is known for its significant contributions to COVID-19 prevention and treatment with products like Comirnaty and Paxlovid. It also has a strong portfolio in biosimilars and innovative treatments across other serious health conditions. Founded in 1849 and based in New York, Pfizer collaborates with several other healthcare giants to improve global health.

PFE Articles

24/7 Wall St. Insights: The election results could spark market turbulence Raising cash makes sense after a 2-year market rally Sit back and let dividends do the heavy lifting for a simple, steady...
Baby Boomer investors who aren’t happy with the falling rates on their savings and CDs may be enticed by the dividend stocks right about now. Specifically, the super-high-yield stocks look that...
For investors concerned about inflation, these five dividend stocks offer dependable, high-yield payouts that can continue regardless of price increases.
With the stock market trading at all-time highs and interest rates headed lower, growth and income investors may want to consider these dividend stocks.
24/7 Wall St. Insights Big money hedge funds are buying high-yield blue chips, expecting rates to drop further. Wall Street sees the federal funds rate at 3% by 2026. Sit back and let dividends do...
Here are five top Goldman Sachs dividend-paying stock picks that investors can buy now and hold for the next decade or longer.
Investing in the stock market has long proven itself as a winning formula for generating wealth, though there are many paths to profits. One of the best is buying dividend stocks. Dividend stock...
The Standard & Poor’s 500 Index was created by credit agency Standard & Poor’s in 1957. While the index is not specifically the top 500 U.S.  companies per se, it does represent a good...
Over the past decade, local computer storage has become a relic, joining the likes of the floppy disk and CD-ROM. Today, Big Data is big business, and the companies that provide cloud storage...
Baby Boomers looking to put new money to work may wish to check out the broader basket of dividend stocks while interest rates are still relatively elevated. Undoubtedly, rates are bound to fall from...
As we move further into October, many investors may be looking to identify certain stocks with the potential to provide additional capital appreciation upside, but also some strong dividend income....
Investing in the stock market has been the surest way to build wealth over time. Year-to-year, however, there are numerous ups and downs. And you don’t even have to look back all that far either to...
These five top stocks trade at reasonable levels and offer the strength that makes sense as we enter a very volatile time of year for stocks.
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are for the next decade of growth.
The Bill & Melinda Gates Foundation is one of the world’s biggest philanthropic organizations. Once the world’s richest man, Bill Gates has fallen to seventh on the list with a net worth of...